Texto: 
standard treatment: abvd w/xrt
adriamycin [doxorubicin], bleomycin, vinblastine, dacarbazine

prognosis is good, especially for young pts with early-stage disease 5 year survival rate of 90%
• anterior (superior) mediastinal mass, surrounding the great vessels and aortic arch.
nodular sclerosing hodgkin’s lymphoma
mediastinal mass:
• thymoma 
- most common 1° anterior mediastinal mass (20%)
• lymphoma
• germ cell tumors
• mediastinal cysts
• pericardial, bronchogenic, enteric, thymic
• aneurysm of ascending aorta
• thyroid/parathyroid tissue
a previously healthy 23 y/o woman presents with a 4-month history of itchy skin, night sweats, and a 20-lb unintentional weight loss.
• signs & symptoms
often asymptomatic 
most common = painless lymphadenopathy
1/3 of pts present w/systemic symptoms
fatigue, generalized pruritis, “b” symptoms [low-grade fever, night sweats, weight loss]
mediastinal masses may also produce mass effects

• subtypes
nodular sclerosing
mixed cellularity 
lymphocyte-depleted
lymphocyte-rich
nodular lymphocyte-predominant

• nodular sclerosing subtype
most common subtype in the us
affects females > males
median age of onset = mid-20’s

• bimodal peak distribution of onset 
young adults (15-35) and late adulthood (>55)
associated with ebv and hiv

http://www.uptodate.com/contents/anterior-mediastinal-mass-lesions
http://emedicine.medscape.com/article/201886-overview


Keywords by value: 
- •: 0.08357409875178069
- mediastinal: 0.08062516929168317
- sclerosing: 0.06739091077697247
- nodular: 0.06372284101532287
- pts: 0.052667970365069636
- subtype: 0.05129774209993844
- sweats: 0.04323799738120063
- =: 0.039864756299379266
- ]: 0.03974856001878057
- [: 0.039633863086905835
- abvd: 0.039180081884295545
- w/xrt: 0.039180081884295545
- dacarbazine: 0.039180081884295545
- 1°: 0.039180081884295545
- thyroid/parathyroid: 0.039180081884295545
- 4-month: 0.039180081884295545
- itchy: 0.039180081884295545
- 20-lb: 0.039180081884295545
- w/systemic: 0.039180081884295545
- lymphocyte-depleted: 0.039180081884295545
- lymphocyte-rich: 0.039180081884295545
- lymphocyte-predominant: 0.039180081884295545
- mid-20: 0.039180081884295545
- //www.uptodate.com/contents/anterior-mediastinal-mass-lesions: 0.039180081884295545
- //emedicine.medscape.com/article/201886-overview: 0.039180081884295545
- night: 0.03690737182092828
- early-stage: 0.03609942774847357
- 15-35: 0.03609942774847357
- young: 0.03308238420586432
- adriamycin: 0.032027024495699545
- bleomycin: 0.032027024495699545
- vinblastine: 0.032027024495699545
- bimodal: 0.03121670646550419
- common: 0.02981689615941863
- pruritis: 0.028946370359877568
- cellularity: 0.028946370359877568
- http: 0.02876256531538023
- unintentional: 0.028522769560747233
- symptoms: 0.028395433025308524
- doxorubicin: 0.02745093819711662
- ebv: 0.02745093819711662
- weight: 0.02722618475680769
- most: 0.02630446855637435
- subtypes: 0.02564887104996922
- adulthood: 0.025442115424925256
- >: 0.025237044574831682
- 1/3: 0.02469965282642229
- thymic: 0.02453191803538742
- onset: 0.02397707756377911
- thymoma: 0.02377681120518565
- hodgkin: 0.023640048277777857
- low-grade: 0.023253331046712837
- enteric: 0.022785062088233606
- ’: 0.022702459907959608
- effects: 0.02216389789989957
- loss: 0.022048570421941686
- median: 0.021974744058038256
- males: 0.02188310278158165
- s: 0.021784601485462997
- lymphoma: 0.021708432305684318
- affects: 0.021618998690600313
- peak: 0.021618998690600313
- females: 0.02113366850408924
- mass: 0.021128195679067815
- produce: 0.02105769324471457
- hiv: 0.02105769324471457
- great: 0.02069615706936367
- pericardial: 0.02042671430573507
- survival: 0.02036183075275217
- ascending: 0.02036183075275217
- fatigue: 0.02029788080852062
- :: 0.02009377450650071
- bronchogenic: 0.020050903692277015
- generalized: 0.019874280009390285
- late: 0.019760313651108787
- germ: 0.019649196752418042
- anterior: 0.019562602877890998
- standard: 0.01943496518878303
- adults: 0.019382982789835513
- painless: 0.01908324376407759
- 55: 0.018411953731131518
- 23: 0.018053014368267263
- prognosis: 0.01801486439630552
- 90: 0.017902340805264233
- b: 0.017902340805264233
- %: 0.017718409185297844
- healthy: 0.01712299463869596
- arch: 0.01709202277506888
- distribution: 0.01709202277506888
- ,: 0.01684418185440899
- mixed: 0.016679659515286806
- aorta: 0.016302328654013536
- good: 0.016250947221119864
- lymphadenopathy: 0.016149932771886283
- previously: 0.015954541112236875
- us: 0.015930710253830718
- especially: 0.015632004699637606
- aortic: 0.015373031774642158
- vessels: 0.01528995562792148
- aneurysm: 0.015010840511303568
- cysts: 0.014877592368139408
- rate: 0.01480320662433708
- skin: 0.014587239712173235
- tumors: 0.014265406034091115
- “: 0.014184448523462932
- ”: 0.01410493934679282
- 20: 0.01365562327180896
- signs: 0.013366115262160241
- &: 0.013339501742850807
- fever: 0.012850056118008739
- (: 0.012841986244335298
- asymptomatic: 0.012838188435538165
- masses: 0.012838188435538165
- ): 0.012685114526458758
- surrounding: 0.01248517895273229
- superior: 0.012127749764685294
- often: 0.012117660215642898
- age: 0.011559601446863584
- 5: 0.011111824099751836
- y/o: 0.010518351243642848
- cell: 0.010258847607028828
- tissue: 0.009001871948678195
- associated: 0.008962055830700897
- woman: 0.008772901988839583
- present: 0.008577816684140803
- may: 0.008330348306213884
- -: 0.008141015372037172
- presents: 0.007758419091146337
- treatment: 0.0076871864871150535
- also: 0.007487198194089562
- disease: 0.006207722405403129
- a: 0.005287997357581351
- history: 0.005245397945364815
- year: 0.004249356752324065
- for: 0.0032404806606342895
- and: 0.003200160101906106
- of: 0.0031067680212796918
- is: 0.002499070126154336
- in: 0.001872876578401133
- with: 0.00156005568119853
- the: 0.001228882530698896
- .: 0.0003155514319764113
